Greenebaum Cancer Center Research Grant

The Cigarette Restitution Fund (CRF) Program -- the State of Maryland’s long-term commitment to fighting cancer -- provides additional strength to important research initiatives underway at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). For fiscal year 2016, the CRF Program has awarded UMGCCC a $10.4 million research grant that will fund a variety of initiatives to benefit the health of Maryland residents.

One of UMGCCC’s high priorities is "translational research," or taking advances from the laboratory and applying them to help cancer patients at the bedside. Translational research enables Marylanders with cancer to take part in clinical trials of promising new therapies without having to travel out of state to access the latest treatments.

The CRF Program also enables UMGCCC specialists to develop and offer innovative approaches to patient care. These approaches include using new technology to deliver cancer-fighting drugs or radiation directly to tumors. These focused treatments can target the disease more precisely and, at the same time, reduce the chance of side effects. With our clinical trials and innovative treatment methods, UMGCCC provides new reasons for hope to people who thought they had exhausted all of their options.

UMGCCC focuses its research funding from the CRF Program on earlier diagnosis and better treatment for several of the most common cancers affecting Maryland residents. These include breast and prostate cancers, as well as those of the gastrointestinal tract and oral, head and neck cancers. Examples of important research programs include:
• A genomics laboratory, which finds and analyzes specific genes involved in cancer, and
• A proteomics laboratory to make possible specialized and routine analysis of proteins and peptides, whose structures could provide clues into new ways to detect and treat cancer

Such initiatives not only provide a deeper understanding of cancer, they also point the way to new treatments.

Through the CRF Program, UMGCCC is able to attract some of the nation's top scientists and cancer specialists to join its impressive array of experts. Patients at the Cancer Center benefit from the expertise of teams of specialists who bring together a wide range of experience and treatment approaches to provide comprehensive care.

In summary, the Cigarette Restitution Fund Program enables UMGCCC to invest in people, technology and facilities to generate research breakthroughs that will improve the diagnosis, treatment and survival of people faced with cancer in the years to come.